Kaneka Endovascular Embolization and Protection

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 164 participants.

Also called NCT05563051

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 164 participants (planned count) (from the registry)
Sponsor
Kaneka Medical America LLC (from the registry)
Registry
  • NCT NCT05563051
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05563051. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Kaneka Endovascular Embolization and Protection
Acronym
KEEP
Condition
Aneurysm Cerebral
Intervention (Device)
i-ED COIL
Lead sponsor
Kaneka Medical America LLC (class: industry)

Record details

Record id
cardio:ct-nct05563051
Content hash
0c5f15da16293f61ac49b2eedfc5bc1706ab6f759c504be6b75e7c2849ece07d